水通道蛋白对子宫颈癌细胞系的迁移及局部浸润潜能的影响研究
详细信息    本馆镜像全文|  推荐本文 |  |   获取CNKI官网全文
摘要
研究背景:子宫颈癌是女性生殖系统最常见的恶性肿瘤之一,在一些发展中国家妇女中其发病率仍居第一位。文献报道,从1980年至2010年,子宫颈癌患者每年从37.8万增加到45.4万,平均年增长率为0.6%。在发展中国家,76%的子宫颈癌发生在不发达地区。近年来随着宫颈癌普查普治工作的广泛开展,一些国家和地区的宫颈癌患病率和死亡率明显下降,但是年轻妇女宫颈癌的发病率有上升趋势。同处新疆的维吾尔族与哈萨克族相比,前者死亡率较后者(9.67/10万)高一倍左右。目前,手术、放化疗是宫颈癌的主要治疗手段。对于早期宫颈癌患者,手术治疗是较为有效的治疗方法;但是中晚期宫颈癌患者失去手术机会,不得不采用放化疗方法治疗,放化疗的副作用常常使治疗难以继续进行。浸润和转移是宫颈癌疗效差、预后不良的重要因素,因此深入研究宫颈癌浸润、转移的机制对其临床治疗具有重要的意义。多年研究表明,为满足快速增殖、分裂和侵袭转移的需要,肿瘤细胞内一系列酶的活性和表达会发生改变,细胞基本结构成分如蛋白质、脂类和核酸的合成加强。癌细胞所有生命活动都离不开水的微环境和参与,它比正常细胞更需要水分子的快速跨膜转运,同时癌细胞向周围基质浸润和进出血管(淋巴管)时需要其体积和细胞形态的改变。水通道蛋白(AQPs)是一组能选择性跨细胞质膜由渗透压驱动转运水分子的小而完整的糖蛋白,迄今为止共发现有13个成员(AQP0-12)。源于基因敲除小鼠的大量研究提示AQPs参与的生理病理功能有尿的浓缩、外分泌腺分泌、脑水肿、神经信号传导、皮肤水分增加、脂肪代谢等。近期对AQPs的一些研究提示AQPs参与细胞的迁移和增殖,可能增强肿瘤的局部侵袭力和通过血管(淋巴管)转移的能力。本研究应用荧光实时定量PCR(Real-Time PCR,RT-PCR)、免疫荧光及免疫组织化学初步筛选出在子宫颈癌中特异表达的AQP1、AQP3、AQP8三个亚型,选取AQP8基因作为目的基因,然后通过荧光蛋白标记的慢病毒载体转染入SiHa细胞基因组内,分别从AQP8基因过表达和表达沉默两方面,探讨AQP8基因对SiHa细胞迁移、增殖、基质贴附及局部浸润的影响。目的:筛选在子宫颈癌中特异表达的AQP亚型,探讨特异AQP亚型对子宫颈癌细胞体外、体内迁移增殖、基质贴附及局部浸润的影响。方法:1)通过水通透性实验比较四种人子宫颈癌细胞系SiHa、HeLa、Caski、ME-180水通透性差异,从中选择水通透性低的细胞系作为实验用细胞系,应用RT-PCR、免疫荧光筛选子宫颈癌细胞系中特异表达的AQP亚型,进一步通过免疫组化筛选子宫颈癌组织中特异表达的AQP亚型;2)构建AQP8过表达质粒pLVX-AQP8-IRES-tdTomato→用磷酸钙转染方法包装慢病毒→感染SiHa细胞→通过红色荧光蛋白(red fluorescence protein,RFP)报告基因筛选稳定过表达AQP8基因的SiHa细胞系;构建AQP8基因沉默质粒pLVX-shRNA2-AQP8-1、 pLVX-shRNA2-AQP8-2、 pLVX-shRNA2-AQP8-3和pLVX-shRNA2-AQP8-4→用lipofectamine2000转染293T细胞,通过Western Blot筛选基因沉默效率最高的质粒→用磷酸钙转染方法包装慢病毒→感染SiHa细胞→通过绿色荧光蛋白(green fluorescence protein,GFP)报告基因筛选稳定AQP8基因沉默的SiHa细胞系;3)通过Transwell侵袭和迁移实验、损伤愈合实验、细胞增殖及贴附实验和裸鼠皮下移植瘤等体外、体内实验探讨AQP8基因对SiHa细胞迁移及局部浸润的影响。结果:1)SiHa中100mOsm与300mOsm、200mOsm与300mOsm组间水通透性差异无统计学意义(P>0.05),400mOsm与300mOsm、500mOsm与300mOsm组间水通透性差异有统计学意义(P<0.05);Caski中100mOsm与300mOsm、200mOsm与300mOsm、500mOsm与300mOsm组间水通透性差异有统计学意义(P<0.05),400mOsm与300mOsm组间水通透性差异无统计学意义(P>0.05);HeLa中100mOsm与300mOsm、400mOsm与300mOsm组间水通透性差异有统计学意义(P<0.05),200mOsm与300mOsm、500mOsm与300mOsm组间水通透性差异无统计学意义(P>0.05);ME-180中各组间水通透性差异均有统计学意义(P<0.05);SiHa中表达的特异AQPs亚型有AQP0、AQP1、AQP2、AQP3、AQP4、AQP5、AQP8。AQP1在慢性宫颈炎、CIN2~3和子宫颈癌组的微血管密度分别是43.6±17.8、56.2±11.6、70.8±21.1,三组间差异有统计学意义(P<0.05);AQP3在慢性宫颈炎、CIN2~3和子宫颈癌组的阳性率分别是13.33%、26.67%、48.57%,子宫颈癌组与慢性宫颈炎组间差异有统计学意义(P<0.05);AQP8在三组间的阳性率分别是46.67%、86.67%、54.29%,三组间差异有统计学意义(P<0.05);2)成功构建AQP8基因过表达的稳定转染SiHa细胞系和AQP8基因沉默的稳定转染SiHa细胞系;(3)AQP8-SiHa侵袭迁移率明显高于对照组(P<0.05);AQP8-SiHa愈合速度明显快于对照组(P<0.05);增殖及贴附能力AQP8-SiHa与对照组相比无明显差异(P>0.05);皮下移植瘤实验显示AQP8-SiHa组肿瘤向皮下脂肪及肌肉组织指样浸润,但对肿瘤大小无明显影响(P>0.05)。AQP8shRNA-SiHa侵袭迁移率明显低于对照组(P<0.05);AQP8shRNA-SiHa愈合速度明显低于对照组(P<0.05);增殖及基质贴附能力AQP8shRNA-SiHa与对照组相比无明显差异(P>0.05)。结论:1)SiHa细胞水通透性最低,在SiHa细胞中表达的AQP亚型可能与Siha细胞的迁移及转移有关;AQP1、AQP3和AQP8的表达可能与子宫颈癌的发生、发展有关;2)本实验建立的AQP8及AQP8shRNA稳定转染SiHa细胞系将用于后续实验宫颈癌中AQP8基因的功能研究,为从体外及体内研究AQP8在子宫颈癌细胞的迁移、浸润中的作用提供了基础;3)AQP8基因的过表达促进SiHa人子宫颈癌细胞的迁移及局部浸润,抑制AQP8基因表达可以抑制SiHa细胞的迁移和潜在的侵袭过程,AQP8可能参与肿瘤的侵袭过程。
Back ground: Cancer of cervix is the most common one of malignant tumors in thefemale genital system, it is still the first incidence in the women in some developpingcountries. Some documents reported that patients of cancer of cervix increased from378,000to454,000from1980to2010, the mean annual incremental rate was0.6%. In somedevelopping countries,76%of cervical cancer patients take residence in unde-veloppedareas. For the past few years, along with widespread mass screening for cancer of cervix,the prevalence and mortality for cancer of cervix descend obviously in some countriesand regions, but incidence of cancer of cervix for young women takes on increasingtendency. In Xinjiang, compared with Hazakh, the death rate of the Uygur nationalitywas higher about one time than Hazakh (9.67/100,000). Now, operation andchemoradiation are the leading therapeutic tools for cance of cervix. For cervical cancerpatients in the early stage, operation is more effective therapy, chemoradiation has to beused because the cervical cancer patients in the middle or advanced stage have nooperation opportunity, but the side-effects of chemoradiation often make therapies not tokeep going. Metastasis and infiltration are the important factors of mal-curative effectand unfavourable prognosis for cancer of cervix, so further study on the mechanism ofmetastasis and infiltration of cancer of cervix is of the considerable significance for itsclinical treatment. Researches of many years show that enzymatic active and expressionin tumor cells can change to adapt to their fast proliferation, mitoses, infilitration andmetastasis, for example, synthesis of protein, lipids and nucleic acid enhance. All vitalmovements of cancer cells depend on water microenvironment, which furtherly needsfast water transmembrane transport compared with normal cells, and the volume andmorphology of cancer cells will change when they infiltrate surrounding substrates andblood or lymphatic vessels. A lot of studies from knockout mice implicate AQPs to takepart in many expected physiological functions, including urine concentration andexocrine gland secretion, as well as, including brain swelling, neural signal transduction, skin moisturization, and fat metabolism. The aquaporins (AQPs) are a family of small,integrate glucoproteins, facilitating osmotically driven water transport selectively acrosscell plasma membranes. Up to now, there are13members (AQP0~12). Recently somestudies on AQPs indicated that AQPs took part in cell migration and proliferation andenhanced local invasiveness and metastasis via blood and lymph vessels. In this study,preliminarily screening AQP1, AQP3, and AQP8subtypes expressing in cancer of cervixby using flourescent real-time PCR (RT-PCR), immunofluorescence and immunohisto-chemistry, and then selecting AQP8gene as the aim gene, transfecting aim gene AQP8into SiHa cells by lentivirus vector, probing the AQP8influence on migration, prolifera-tion, substrate adherence and local invasiveness of SiHa cells according to AQP8geneoverexpression and expression silence, respectively. Objective: To screen AQPssubtypes idio-expressing in cancer of cervix, and to investigate AQP subset effects onmigration, proliferation, substrate adherence and local invasiveness of SiHa cells in vivoand in vitro. Methods:1) Comparing the difference of osmotic water permeability in4kinds of cervical carcinoma cell lines SiHa, HeLa, Caski, ME-180by osmotic waterpermeability measurement and selecting cervical carcinoma cell line of low waterpermeability for the experiment, and then examining expression of isoforms ofaquaporins by Real-Time PCR and immunofluorescence, furtherly selecting idio-aquaporins expressing in cervical carcinoma tissues by immunohistochemistry;2)Building AQP8overexpression plasmid pLVX-AQP8-IRES-tdTomato, packaginglentivirus particles by calcium phosphate transfection, then infect SiHa cells, screeningstably expressing AQP8SiHa cell line by RFP (red fluorescence protein) reporter gene;building AQP8gene silent plasmids, pLVX-shRNA2-AQP8-1, pLVX-shRNA2-AQP8-2,pLVX-shRNA2-AQP8-3and pLVX-shRNA2-AQP8-4, transfecting293T cells usinglipofectamine2000, screening highest silent rate plasmid by Western Blot, packaginglentivirus particles by calcium phosphate transfection, then infecting SiHa cells,screening stably expressing AQP8gene silence SiHa cell line by GFP (greenfluorescence protein) reporter gene;3) Probing AQP8gene influence on migration andlocal invasion of SiHa cells by transwell migration and invasion assays, wound healingassay, tumor cell growth, substrate adherence assays and subcutaneous xenografts assay.Results:1) In SiHa, osmotic water permeability differences between100mOsm and300mOsm groups,200mOsm and300mOsm groups were not significant (P>0.05),osmotic water permeability differences between400mOsm and300mOsm groups,500mOsm and300mOsm groups were significant (P<0.05); In Caski, osmotic water permeability differences between100mOsm and300mOsm groups,200mOsm and300mOsm,500mOsm and300mOsm groups were significant (P<0.05), osmotic waterpermeability differences between400mOsm and300mOsm groups were not significant(P>0.05); In HeLa, osmotic water permeability differences between100mOsm and300mOsm groups,400mOsm and300mOsm groups were significant (P<0.05), osmoticwater permeability differences between200mOsm and300mOsm,500mOsm and300mOsm groups were not significant (P>0.05); In ME-180, osmotic water permeabilitydifferences among groups were significant (P<0.05); AQP0, AQP1, AQP2, AQP3,AQP4, AQP5, AQP8were isoforms of aquaporins expressing in SiHa cells; MVD ofAQP1were43.6±17.8,56.2±11.6,70.8±21.1, respectively, in control group, CIN3and cervical carcinoma group. Difference among three groups was significant (P<0.05);Positive rates of AQP3were13.33%,26.67%,48.57%, respectively, in control group,CIN3and cervical carcinoma group. Difference between cervical carcinoma and controlgroup was significant (P<0.05); Positive rates of AQP8were46.67%,86.67%,54.29%,respectively, in the three groups. Difference among three groups was significant (P<0.05);2) Sucessfully building stable infection SiHa cell lines expressing AQP8gene andsilencing AQP8gene;3) Migration and invasion rate of AQP8-SiHa was obviouslyquicker than control groups (P<0.05); Wound healing speed of AQP8-SiHa wasobviously quicker than control groups (P<0.05); The difference of proliferation andsubstrate adherence between AQP8-SiHa and control groups was not significant (P>0.05); The xenografts with AQP8showed finger-like local invasiveness intosubcutaneous adipose and muscle, but had no effects on tumor volumes (P>0.05);Migration and invasion rate of AQP8shRNA-SiHa was obviously lower than controlgroups (P<0.05); Wound healing speed of AQP8shRNA-SiHa was obviously lower thancontrol groups (P<0.05); The difference of proliferation and substrate adherencebetween AQP8shRNA-SiHa and control groups was not significant (P>0.05); Thexenografts with AQP8shRNA showed no significance in local invasion and tumorvolumes compared with control group (P>0.05). Conclusions:1) Osmotic waterpermeability of SiHa cells is the lowest, and subsets of aquaporins expressing in Sihacells may be related with their migration and infiltration; Expression of AQP1, AQP3andAQP8in cervical carcinoma may be related with cervical carcinogenesis anddevelopment;2) Stable infection SiHa cell lines expressing AQP8gene and AQP8shRNA are used to study AQP8gene function in cervical carcinoma, and provide theresearch basis for AQP8gene effects on the migration and invasion of SiHa cells in vivo and in vitro;3) Overexpression of AQP8gene facilitates the migration and localinvasiveness potential of SiHa cells, suppression of AQP8gene expression can inhibit themigration and local invasiveness potential of SiHa cells, AQP8gene may participate inthe invasive process of tumors.
引文
[1]曹泽毅主编.中华妇产科学.第二版[M].北京人民卫生出版社.2005:2012-2015.
    [2] Mohammad H Forouzanfar, Kyle J Foreman, Allyne M Delossantos, et al. Breastand cervical cancer in187countries between1980and2010:a systematicanalysis[J]. Lancet.2011,378:1461-1484.
    [3]卞美璐. WHO(2006年)宫颈癌综合防治实践指南简介[J].中国实用妇科与产科杂志.2007,23(7):557-560.
    [4] Murthy NS, Sehgal A, Satyanarayana L, et al. Risk factors related to biologicalbehaviour of precancerous lesions of the uterine cervix[J]. Br J Cancer.1990,61(5):732-736.
    [5] Schneider A, Koutsky LA. Natural history and epidemiological features of genitalHPV infection[J]. IARC Sci Publ1992;119:25-52.
    [6]彭玉华,拉莱·苏祖克,周康.子宫颈癌4505例临床分析[J].中华妇产科志.2003,12(38):764-765.
    [7] Arge P, King LS, Yasui M, Guggino WB, et al. Aquaporin water channels-fromatomic structure to clinical medicine[J]. J Physiol.2002,542:3-16.
    [8] Verkman AS, Hara-Chikuma M, Papadopoulos MC. Aquaporins new players incancerbiology[J]. J Mol Med.2008,86(5):523-529.
    [9] Verkman AS. More than just water channels:unexpected cellular roles ofaquaporins[J]. J Cell Sci.2005,118:3225-3232.
    [10] Eilert-Olsen M, Haj-Yasein NN, Vindedal GF, et al. Deletion of aquaporin-4changesthe perivascular glial protein scaffold without disrupting the brain endothelialbarrier[J]. Glia.2011,30. doi:10.1002/glia.22277.[Epub ahead of print]
    [11] Yamamura Y, Motegi K, Kani K, Takano H, et al. TNF-α inhibits aquaporin5expression in human salivary gland acinar cells via suppression of histone H4acetylation[J]. J Cell Mol Med.2011,5. doi:10.1111/j.1582-4934.2011.01456.x.[Epub ahead of print]
    [12] Iizuka T, Suzuki T, Nakano K, et al. Immunolocalization of aquaporin-5in normalhuman skin and hypohidrotic skin diseases[J]. J Dermatol.2011,28. doi:10.1111/j.1346-8138.2011.01327. x.[Epub ahead of print].
    [13] Zhu JG, Wu M, Liu YN, et al. Expressions of aquaporins1and3in the mouseprostate and their significance[J]. Zhonghua Nan Ke Xue.2011,17(6):483-487.
    [14] Lee JS, Agrawal S, Turkovich MV, et al. Water channels in platelet volumeregulation[J]. J Cell Mol Med.2011,21. doi:10.1111/j.1582-4934.2011.01362.x.[Epub ahead of print]
    [15] Karasawa K, Tanaka A, Jung K, et al. Patterns of aquaporin expression in the canineeye[J]. Vet J.2011,190(2):e72-77.
    [16] Yakata K, Tani K, Fujiyoshi Y. Water permeability and characterization ofaquaporin-11[J]. J Struct Biol.2011,174(2):315-320.
    [17] Warth A, Kroger S, Wolburg H. Redistribution of aquaporin-4in humanglioblastoma correlates with loss of agrin immunoreactivity from brain capillarybasal laminae[J]. Acta Neuropathol.2004,107:311-318.
    [18] Saadoun S, Papadopoulos MC, Davies DC, et al. Aquaporin-4expression isincreased in oedematous human brain tumors[J]. J Neurol Neurosurg Psychiatry.2002,72:262-265.
    [19] Fischer H, Stenling R, Rubio C, et al. Differential expression of aquaporin8inhuman colonic epithelial cells and colorectal tumors[J]. BMC Physiol.2001,1:1.
    [20] Moon C, Soria JC, Jang SJ, et al. Involvement of aquaporins in colorectalcarcinogenesis[J]. Oncogene.2003,22:6699-6703.
    [21] Warth A, Simon P, Capper D, et al. Expression pattern of the water channelaquaporin-4in human gliomas is associated with blood-brain barrier disturbancebut not with patient survival[J]. J Neurosci Res.2007,85:1336-1346.
    [22] Aishima S, Kuroda Y, Nishihara Y, et al. Down-regulation of aquaporin-1inintrahepatic cholangiocarcinoma is related to tumor progression and mucinexpression[J]. Hum Pathol.2007,38:1819-1825.
    [23] Mazal PR, Susani M, Wrba F, et al. Diagnostic significance of aquaporin-1in livertumors[J]. Hum Pathol.2005,36:1226-1231.
    [24] Warth A, Mittelbronn M, Hulper P, et al. Expression of the water channel proteinaquaporin-9in malignant brain tumors[J]. Appl Immunohistochem Mol Morphol.2007,15:193-198.
    [25] Saadoun S, Papadopoulos MC, Davies DC, et al. Increased aquaporin1waterchannel expression in human brain tumours[J]. Br J Cancer.2002,87:621-623
    [26] Oshio K, Binder DK, Liang Y, et al. Expression of the aquaporin-1water channel inhuman glial tumors[J]. Neurosurgery.2005,56:375-381;discussion375-381.
    [27] Endo M, Jain RK, Witwer B, et al. Water channel(aquaporin1)expression anddistribution in mammary carcinomas and glioblastomas[J]. Microvasc Res.1999,58:89-98.
    [28] Markert JM, Fuller CM, Gillespie GY, et al. Differential gene expression profiling inhuman brain tumors[J]. Physiol Genomics.2001,5:21-33.
    [29] Boon K, Edwards JB, Eberhart CG, et al. Identification of astrocytoma associatedgenes including cell surface markers[J]. BMC Cancer.2004,4:39.
    [30] Guan B, Zhu D, Dong Z, et al. Expression and distribution of aquaporin1inlaryngeal carcinoma. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi[J].2007,21:269-272.
    [31] Jablonski EM, Mattocks MA, Sokolov E, et al. Decreased aquaporin expressionleads to increased resistance to apoptosis in hepatocellular carcinoma[J]. CancerLett.2007,250:36-46.
    [32] Chen Y, Tachibana O, Oda M, Xu R, et al. Increased expression of aquaporin1inhuman hemangioblastomas and its correlation with cyst formation[J]. J Neurooncol.2006,80:219-225.
    [33] Liu YL, Matsuzaki T, Nakazawa T, et al. Expression of aquaporin3(AQP3)innormal and neoplastic lung tissues[J]. Hum Pathol.2007,38:171-178.
    [34] Hoque MO, Soria JC, Woo J, et al. Aquaporin1is overexpressed in lung cancer andstimulates NIH-3T3cell proliferation and anchorage-independent growth[J]. Am JPathol.2006,168:1345-1353.
    [35] Longatti P, Basaldella L, Orvieto E, et al. Aquaporin(s)expression in choroid plexustumours[J]. Pediatr Neurosurg.2006,42:228-233.
    [36] Yang JH, Shi YF, Cheng Q, et al. Expression and localization of aquaporin-5in theepithelial ovarian tumors[J]. Gynecol Oncol.2006,100:294-299.
    [37] Kafe H, Verbavatz JM, Cochand-Priollet B, et al. Collecting duct carcinoma:anentity to be redefined[J]? Virchows Arch.2004,445:637-640.
    [38] Takenawa J, Kaneko Y, Kishishita M, et al. Transcript levels of aquaporin1andcarbonic anhydrase IV as predictive indicators for prognosis of renal cell carcinomapatients after nephrectomy[J]. Int J Cancer.1998,79:1-7.
    [39] Saadoun S, Papadopoulos MC, Hara-Chikuma M, Verkman AS, et al. Impairment ofangiogenesis and cell migration by targeted aquaporin-1gene disruption[J]. Nature.2005,434:786-792.
    [40] Hu J, Verkman AS. Increased migration and metastatic potential of tumor cellsexpressing aquaporin water channels[J]. FASEB J.2006,20:1892-1894.
    [41] Papadopoulos MC, Verkman AS. Aquaporins and cell migration[J]. Pflugers Archdoi.2007,10.1007/s00424-007-0357-5.
    [42] Janghee Woo, JunaLee, Young Kwang Chae et al. Overexpression of AQP5,aputative oncogene, promotes cell growth and transformation[J]. Cancer Let.2008,264:54-62.
    [43] Kusayama M, Wada K, Nagata M, et al. Critical role of aquaporin3on growth ofhuman esophageal and oral squamous cell carcinoma[J]. Cancer Sci.2011,102(6):1128-1136.
    [44] Shen L, Zhu Z, Huang Y, et al. Expression profile of multiple aquaporins in humangastric carcinoma and its clinical significance[J]. Biomed Pharmacother.2010,64(5):313-318.
    [45] Yang JH, Yu YQ, Yan CX. Localisation and expression of aquaporin subtypes inepithelial ovarian tumours[J]. Histol Histopathol.2011,26(9):1197-205.
    [46] Wang D, Owler BK. Expression of AQP1and AQP4in paediatric brain tumours[J]. JClin Neurosci.2011,18(1):122-127.
    [47] Watanabe T, Fujii T, Oya T, et al. Involvement of aquaporin-5in differentiation ofhuman gastric cancer cells[J]. J Physiol Sci.2009,59(2):113-122.
    [48] Zhang ZQ, Zhu ZX, Bai CX, et al. Aquaporin5expression increases mucinproduction in lung adenocarcinoma[J]. Oncol Rep.2011,25(6):1645-1650.
    [49] López-Campos JL, Sánchez Silva R, Gómez Izquierdo L, et al. Overexpression ofAquaporin-1in lung adenocarcinomas and pleural mesotheliomas[J]. HistolHistopathol.2011,26(4):451-459.
    [50] Arne Warth, Thomas Muley, Michael Meister, et al. Loss of aquaporin-4expressionand putative function in non-small cell lung cancer[J]. BMC Cancer.2011,11:161-169.
    [51] S. Jarius, A. Warth, K. P. Wandinger, et al. Antibodies to aquaporin-4in non-smallcell lung cancer:a study on50patients[J]. Neurol Sci.2010,31(6):871-872.
    [52] Li J, Tang H, Hu X, et al. Aquaporin-3gene and protein expression in sun-protectedhuman skin decreases with skin ageing[J]. Australas J Dermatol.2010,51(2):106-112.
    [53] Zhang W, Xu Y, Chen Z, et al. Knockdown of aquaporin3is involved in intestinalbarrier integrity impairment[J]. FEBS Lett.2011,585(19):3113-3119.
    [54] Kim SO, Song SH, Hwang EC, et al. Changes in aquaporin(AQP)2and AQP3expression in ovariectomized rat urinary bladder:potential implication of waterpermeability in urinary bladder[J]. World J Urol.2011,11.[Epub ahead of print].
    [55] Satake M, Ikarashi N, Kagami M, et al. Increases in the expression levels ofaquaporin-2and aquaporin-3in the renal collecting tubules alleviate dehydrationassociated with polyuria in diabetes mellitus[J]. Biol Pharm Bull.2010,33(12):1965-1970.
    [56] Matsuzaki T, Hata H, Ozawa H, et al. Immunohistochemical localization of theaquaporins AQP1, AQP3, AQP4, and AQP5in the mouse respiratory system[J].Acta Histochem Cytochem.2009,42(6):159-169.
    [57] Verkman AS, Ruiz-Ederra J, Levin MH. Functions of aquaporins in the eye. ProgRetin Eye Res[J].2008,27(4):420-433.
    [58] DiGiovanni J. Multistage carcinogenesis in mouse skin[J]. Pharmacol Ther.1992,54:63-128.
    [59] Hara-Chikuma M, Verkman AS. Prevention of skin tumorigenesis and impairment ofepidermal cell proliferation by targeted aquaporin-3gene disruption[J]. Mol CellBiol.2008,28:326-332.
    [60] Hara M, Ma T, Verkman AS. Selectively reduced glycerol in skin ofaquaporin-3-deficient mice may account for impaired skin hydration, elasticity, andbarrier recovery[J]. J Biol Chem.2002,277:46616-46621.
    [61] Hara M, Ma T, Verkman AS. Glycerol replacement corrects defective skin hydration,elasticity, and barrier function in aquaporin-3-deficient mice[J]. Proc Natl Acad SciU S A.2003,100:7360-7365.
    [62] Thiagarajah JR, Zhao D, Verkman AS. Impaired enterocyte proliferation inaquaporin-3deficiency in mouse models of colitis[J]. Gut.2007,56:1529-1535.
    [63]郝利铭,陈爱军,高英等. Aquaporin1在中国人肺鳞癌细胞的表达[J].解剖科学进展.2008,14(3):287-289.
    [64]刘锦源,张石江*,金宇1等.水通道蛋白1在肺腺癌组织中的表达和分布[J].南京医科大学学报.2008,28(4):445-448.
    [65] Hoque MO, Soria JC, Woo J, et al. Aquaporin1Is Overexpressed in Lung Cancerand Stimulates NIH-3T3Cell Proliferation and Anchorage-Independent Growth[J].Amer J Pathol,2006,168(4):1345-1353.
    [66]张红旭,张明昌,陈宏. RNA干扰抑制水通道蛋白1对血管内皮细胞迁移影响的研究[J].中华眼科杂志.2008,44(8):741~744.
    [67]胡晓继,廖书杰,王世宣,卢运萍,马丁.水通道蛋白1在宫颈病变中的表达及意义[J].现代妇产科进展.2009,18(7):507-509.
    [68] de Wilde J, Wilting SM, Meijer CJ, et al. Gene expression profiling to identifymarkers associated with deregulated hTERT in HPV-transformed keratinocytes andcervical cancer[J]. Int J Cancer,2008,122(4):877-888.
    [69]李永明,冯学超,杨红等.水通道蛋白AQP1的表达促进SMMC-7221人肝癌细胞系的迁移[J].科学通报.2006,51(17):2024-2029.
    [70] Richart R, Ludwig AS Jr. Alterations in chromosomes and DNA content ingynecologic neoplasms[J]. Am J Obstet Gynecol.1969,104(4):463-471.
    [71] Narayan G, Scotto L, Neelakantan V, et al. Protocadherin PCDH10, involved intumor progression, is a frequent and early target of promoter hypermethylation incervical cancer[J]. Genes Chromosomes Cancer.2009,48(11):983-992.
    [72] Otto-Wilhelm Merten and Mohamed Al-Rubeai. Viral Vectors for GeneTherapy:Methods and Protocols, Methods in Molecular Biology[J]. Humana Press.2011:183.
    [73] Howard, KA. Delivery of RNA interference therapeutics Using polycation-basednanoparticles[J]. Adv. Drug Deliv. Rev.2009,61,710-720.
    [74] Iorns, E., Lord, CJ., Turner, N., and Ashworth, A. Utilizing RNA interference toenhance cancer drug discovery[J]. Nat. Rev. Drug Discov.2007,6,556-568.
    [75] Chou, MI., Hsieh, YF., Wang, M., et al. In vitro and in vivo targeted delivery ofIL-10interfering RNA by JC virus like particles[J]. J. Biomed. Sci.2010,24,17-51.
    [76]宗敏茹,金淑杰,张晓静等.水通道蛋白在肿瘤细胞中的表达及意义[J].中国实验诊断学,2008,12(11):1341-1343.
    [77]李琦,张宝.水通道蛋白1在鼻咽癌组织中的表达[J].肿瘤防治研究.2010,37(9):1028-1030.
    [78]关桂梅,董震,孙克巍.喉癌组织中水通道蛋白1的表达与微血管生成的相关性研究及意义[J].临床耳鼻咽喉头颈外科杂志.2009,23(5):219-221.
    [79]叶昇,荣健,龙友明等.水通道蛋白4和高迁移率族蛋白1在晚期胃癌中的表达[J].中山大学学报(医学科学版).2011,32(1):56-59.
    [80]刘明,孙颖,薛翔等.宫颈鳞癌组织中AQPl和AQP4的表达及意义[J].现代妇产科进展.2008,17(11):824-827.
    [81]赵玉荣,赖爱鸾,王丽芳等.宫颈阴道组织水通道蛋白-2的表达水平及其相关因素研究[J].实用妇产科杂志.2010,26(1):52-56.
    [82]姚济芬,周彩云,韦兰芳等.子宫颈癌组织中水通道蛋白8和bcl-2蛋白的表达及其相关性[J].中华妇产科杂志,2008,43(3):205-208.
    [83]文建国张宁李留霞.水通道蛋白在妇科肿瘤中的研究进展[J].中国妇产科临床杂志.2008,9(3):235-236.
    [84] Weidner N, Semple JP, Weleh WR, et al. Tumor angiogenesis and metastasiscorrelation in invasive breast carcinoma[J]. N Engl J Med,1991,324(1):1-8.
    [85] Fromowitz FB, Viola MV, Chao S, et aL. Ras p2l expression in the progression ofbreast cancer. Hum Pathol.1987,18:1268-1275.
    [86] Harlozinska A. Progress in molecular mechanisms of tumor metastasis andangiogenesis[J]. Anticancer Res.2005,25:3327-3333.
    [87] Mobasheri A, Airley R, Hewitt S M, et al. Heterogeneous expression of theaquaporin1(AQP1)water channel in tumors of the prostate, breast, ovary, colon andlung:a study using high density multiple human tumor tissue microarrays[J]. Int JOncol.2005,26:1149-1158.
    [88] Solenov, E., Watanabe, H., Manley, G. T., andVerkman, A. S. Seven fold-reducedosmotic water permeability in primary astrocyte cultures from AQP-4-defcient mice,measured by a fuorescence quenching method[J]. Am. J. Physiol.2004,286,C426-C432.
    [89] Zhihong, Chen, Rong Zhu, Li Bai and Chunxue, Bai. Downregulation of aquaporin5Induced by vector-based short hairpinRNA, and its effect on MUCSAC geneexpression in human airway submucosal gland cells[J]. Respir Physiol Neurobiol.2006,152(2):197-203.
    [90] Krane CM, Melvin JE, Nguyen HV, et al. Sallvary Acinar Cells fromAquaperin5-defieient mice Have Decreased Membrane Water Penneability andAltered Cell Volume Regulation[J]. J Biol Chem.2001,276:23413-23420.
    [91] Portincasa P, Palasciano G, Svelto M, Calamita G. Aquaporins in the hepatobiliarytract. Which, where and what they do in health and disease[J]. Eur J Clin Invest.2008,38:1-10.
    [92] Morishita Y, Matsuzaki T, Hara-chikuma M, Andoo A, Shimono M, Matsuki A, et al.Disruption of aquaporin-11produces polycystic kidneys following vacuolization ofthe proximal tubule[J]. Mol Cell Biol.2005,25:7770-7779.
    [93] Jung HJ, Park JY, Jeon HS, et al. Aquaporin-5:A Marker Protein for Proliferationand Migration of Human Breast Cancer Cells[J]. PloS ONE.2011,6(12):e28492.
    [94]李玉林主编,病理学[M].第7版.人民卫生出版社,2011:86.
    [95] Jablonski EM, Mattocks MA, Sokolov E, et al. Decreased aquaporin expressionleads to increased resistance to apoptosis in hepatocellular carcinoma[J]. CancerLett.2007,250(1):36-46.
    [96] ShengboCao, ChengxiangWu, YongboYang, et al. Lentiviral vector-mediated stableexpression of sTNFR-Fc in human macrophage and neuronal cells as a potentialtherapy for neuroAIDS[J]. Journal of Neuroinflammation.2011,8:481-11.
    [97] JankaMatrai, AlessioCantore, CynthiaC. Bartholomae, et al. Hepatocyte-TargetedExpression by Integrase-Defective Lentiviral Vectors Induces Antigen-SpecicTolerance In Mice with Low Genotoxic Risk[J]. HEPATOLOGY.2011,53(5):1696-1707.
    [98] Wasala NB, Shin JH, Duan D. The evolution of heart gene delivery vectors[J]. JGene Med.2011,13(10):557-565.
    [99] Qin XJ, Dai DJ, Gao ZG, et al. Effect of lentivirus-mediated shRNA targetingVEGFR-3on proliferation, apoptosis and invasion of gastric cancer cells[J]. Int JMol Med.2011,28(5):761-768.
    [100]Fenjves ES, Ochoa MS, Cechin S, et al. Protection of human pancreatic islets usinga lentiviral vector expressing two genes:cFLIP and GFP[J]. Cell Transplant.2008,17(7):793-802.
    [101]SUN Xiang-zhou, LIU Gui-hua, WANG Zhuo-qing, et al. Over-expression of VEGFin the adipose tissue-derived stem165cells via the lentiviral vector[J]. ChineseMedical Journal.2011,124(19):3093-3097.
    [102]Copreni E, Penzo M, Carrabino S, Conese M. Lentivirus-mediated gene transfer tothe respiratory epithelium:a promising approach to gene therapy of cystic fibrosis[J].Gene Ther.2004,11Suppl1:S67-75.
    [103]Zong X, Yang H, Yu Y, et al. Possible role of Pax-6in promoting breast cancer cellproliferation and tumorigenesis[J]. BMB Rep.2011,44(9):595-600.
    [104]Kim SY, Yoon J, Ko YS, et al. Constitutive phosphorylation of the FOXO1transcription factor in gastric cancercells correlates with microvessel area and theexpressions of angiogenesis-related molecules. BMC Cancer[J].2011,22(11):264.
    [105]Alekseev OM, Richardson RT, Tsuruta JK, et al. Depletion of the histone chaperonetNASP inhibits proliferation and induces apoptosis in prostate cancer PC-3cells[J].Reprod Biol Endocrinol.2011,16(9):50.
    [106]Zhao Q, Wang C, Zhu J, et al. RNAi-mediated knockdown of cyclooxygenase2inhibits the growth, invasion and migration of SaOS2human osteosarcoma cells:acase control study[J]. J Exp Clin Cancer Res.2011,5(30):26.
    [107]Guo S, Mao X, Chen J, et al. Overexpression of Pim-1in bladder cancer[J]. J ExpClin Cancer Res.2010,11(29):161.
    [108]Li N, Guo W, Shi J, et al. Expression of the chemokine receptor CXCR4in humanhepatocellular carcinoma and its role in portal vein tumor thrombus[J]. J Exp ClinCancer Res.2010,27(29):156.
    [109]Kremer, K. L., Dunning, K. R., Parsons, D. W., andAnson, D. S. Gene delivery toairway epithelial cells in vivo:a direct comparison of apical and basolateraltransduction strategies using pseudotyped lentivirus vectors[J]. J. GeneMed.2007,9,362-368.
    [110]Liang XJ, Chen XJ, Yang DH, et al. Human umbilical cord mesenchymal stem cellsby hTERT Gene Transfection can differentiate into hepatocyte-like cells in vitro[J].Cell Biol Int.2011,12.[Epub ahead of print].
    [111]Levin MC, Lidberg U, Jirholt P, et al. Evaluation of macrophage-specific promotersusing lentiviral delivery in mice[J]. Gene Ther.2011,1. doi:10.1038/gt.2011.195.[Epub ahead of print]
    [112]ChenWY, Wu XY, LevasseurDN, et a. l Lentiviral vector transductionofhemato-poietic stem cells thatmediate long-term reconstitution of lethallyirradiated mice[J]. Stem Cells.2000,18(5):352-359
    [113]Copreni, E., Nicolis, E., Tamanini, A., et al. Late generation lentiviralvectors:evaluation of inflammatory potential in human airway epithelial cells[J].VirusRes.2009,144,8-17.
    [114]Baka K, Goto-Koshino Y, Mizukoshi F, et al. Inhibition of the replication of felineimmunodeficiency virus by lentiviral vector mediated RNA interference in felinecell lines[J]. J VetMed Sci.2008,70(8):777-783.
    [115]Zhao H, Yang ZC, Zhang JY. Construction of recombinant lentiviral vectors formouse NMNAT1gene expression and its interference RNA[J]. Zhe jiang Da XueXue Bao Yi Xue Ban.2011,40(6):622-629.
    [116]Sun XZ, Liu GH, Wang ZQ, et al. Over-expression of VEGF165in the adiposetissue-derived stem cells via the lentiviral vector[J]. Chin Med J(Engl).2011,124(19):3093-3097.
    [117]Jin GS, Zhu GD, Zhao ZG, et al. VP22enhances the expression ofglucocerebrosidase in human Gaucher II fibroblast cells mediated by lentiviralvectors[J]. Clin Exp Med.2011,28.[Epub ahead of print].
    [118]Nethercott HE, Brick DJ, Schwartz PH. Derivation of induced pluripotent stem cellsby lentiviral transduction. Methods Mol Biol[J].2011,767:67-85.
    [119]Metelo J, Ward N, Thrasher AJ, et al. Lentivectors are efficient tools to manipulatethe dendritic cell cytoskeleton[J]. Cytoskeleton(Hoboken).2011,68(8):434-445.
    [120]Hannon, G. J. RNA interference[J]. Nature.2002,418,244-251.
    [121]Howard, K. A. Delivery of RNA interference therapeutics using polycation-basednanoparticles[J]. Adv. Drug Deliv. Rev.2009,61,710-720.
    [122]Chou, M. I., Hsieh, Y. F., Wang, M., etal. In vitro and in vivo targeted delivery ofIL-10interfering RNA by JC virus-like particles[J]. J. Biomed. Sci.2010,24,17-51.
    [123]Jiang, L., Chen, Y. C., Chan, C. Y., etal. Down-regulation of stathmin is required forTGF-b inducible early gene1induced growth inhibition of pancreatic cancercells[J]. Cancer Lett.2009,274,101-108.
    [124]Jemal A, Siegel R, Ward E, et al. Cancer statistics,2009[J]. CA Cancer J Clin.2009,59(4):225-249.
    [125]Dunne EF, Markowitz LE. Genital human papillomavirus infection[J]. Clin InfectDis.2006,43(5):624-629.
    [126]Ursu RG, Onofriescu M, Nemescu D, et al. HPV prevalence and type distribution inwomen with or without cervical lesions in the Northeast region of Romania[J].Virol J.2011,22,8(1):558.[Epub ahead of print].
    [127]Hussain S, Bharadwaj M, Nasare V, et al. Human papillomavirus infection amongyoung adolescents in India:Impact of vaccination[J]. J Med Virol.2012,84(2):298-305.
    [128]Narayan G, Arias-Pulido H, Koul S, et al. Genetic analysis identifies putative tumorsuppressor sites at2q35-q36.1and2q36.3-q37.1involved in cervical cancerprogression[J]. Oncogene.2003,22(22):3489-3499.
    [129]Rao PH, Arias-Pulido H, Lu XY, et al. Chromosomal amplifications,3q gain anddeletions of2q33-q37are the frequent genetic changes in cervical carcinoma[J].BMC Cancer.2004,4(1):5.
    [130]Ki KD, Lee SK, Tong SY, et al. Role of5'-CpG island hypermethylation of theFHIT gene in cervical carcinoma[J]. J Gynecol Oncol.2008,19(2):117-122.
    [131]Jancárková N, Krkavcová M, Janashia M, et al. Importance of chromosomalchanges correlated to prognostic factors in ovarian and cervical malignant tumors[J].Ceska Gynekol.2008,73(2):79-86.
    [132]Backsch C, Pauly B, Liesenfeld M, et al. Two novel unbalanced whole armtranslocations are frequently detected in cervical squamous cellcarcinoma[J].Cancer Genet.2011,204(12):646-653.
    [133]Lihua Li, Hua Zhang, Tonghui Ma, et al. Very high aquaporin-1facilitated waterpermeability in mouse gallbladder[J]. Am J Physiol Gastrointest Liver Physiol.2009,296(4):G816-G822.
    [134]King L S, Kozono D, Agre P. From structure to disease:the evolving tale ofaquaporin biology[J]. Nature Reviews Molecular Cell Biology.2004,5:687-698.
    [135]王石生,颜春松.肺水通道蛋白与肺疾病[J].实用临床医学.2006,(7)5:151-153.
    [136]Badaut J, Ashwal S, Adami A, et al. Brain water mobility decreases after astrocyticaquaporin-4inhibition using RNA interference[J]. J Cereb Blood Flow Metab.2011,31:819-831.
    [137]Mints M, Hildenbrand A, Lalitkumar LP, et a1. Expression of aquaporin-1inendometrial blood vessels in menorrhagia[J]. Int J Mol Med,2007,19(3):407-411.
    [138]De Falco M, Cobellis L, Torella M, et al. Down-regulation of aquaporin4in humanplacenta throughout pregnancy[J]. In Vivo,2007,21(5):813-817.
    [139]Shengbiao Wang, Amidi F, Shengli Yin, et al. Cyclic adenosine monophosphateregulation of aquaporin gene expression in human amnion epithelia[J]. Reprod Sci.2007,14(3):234-240.
    [140]Jiang, Y. Aquaporin-1activity of plasma membrane affects HT20colon cancer cellmigration[J]. IUBMB Life.2009,61(10):1001-1009.
    [141]La Porta C. AQP1is not only a water channel:It contributes to cell migrationthrough Lin7/beta-catenin[J]. Cell Adh Migr.2010,4(2):204-206.
    [142]Hayashi Y, Edwards NA, Proescholdt MA, et al. Regulation and function ofaquaporin-1in glioma cells[J]. Neoplasia.2007,9(9):777-787.
    [143]McCoy E, Sontheimer H. Expression and function of water channels(aquaporins)inmigrating malignant astrocytes[J]. Glia.2007,55(10):1034-1043.
    [144]Chen Z, Zhang Z, Gu Y, et al. Impaired migration and cell volume regulation inaquaporin5-deficient SPC-A1cells[J]. Respir Physiol Neurobiol.2011,176(3):110-117.
    [145]Huang Y, Zhu Z, Sun M, et al. Critical role of aquaporin-3in the human epidermalgrowth factor-induced migration and proliferation in the human gastricadenocarcinoma cells[J]. Cancer Biol Ther.2010,9(12):1,000-1007.
    [146]Hayashi S, Takahashi N, Kurata N, et al. Involvement of aquaporin-1in gastricepithelial cell migration during wound repair[J]. Biochem Biophys Res Commun.2009,386(3):483-487.
    [147]Shi Z, Zhang T, Luo L, et al. Aquaporins in human breast cancer:Identification andinvolvement in carcinogenesis of breastcancer[J]. J Surg Oncol.2011Nov21.doi:10.1002/jso.22155.
    [148]Huang Y, Zhu Z, Sun M, et al. Critical role of aquaporin-3in the human epidermalgrowth factor-induced migration and proliferation in the human gastricadenocarcinoma cells[J]. Cancer Biol Ther.2010,9(12):1,000-1007.
    [149]Chae YK, Kang SK, Kim MS, et al, Human AQP5plays a role in the progression ofchronic myelogenous leukemia(CML)[J]. PLoS One.2008,3(7):e2594.
    [150]Lauffenburger, D. A., and Horwitz, A. F. Cell migration:a physically integratedmolecular process[J]. Cell.1996,84:359-369.
    [151]Zelenina M, Brismar H. Osmotic water permeability measurements using confocallaser scanning microscopy[J]. Eur Biophys J.2000,29:165–167.
    [152]Maric K, Wiesner B, Lorenz D, et al. Cell volume kinetics of adherent epithelialcells measured by laser scanning reflection microscopy:determination of waterpermeability changes of renal principal cells. Biophys J.1993,80:1783–1790.
    [1] Parkin DM:Global cancer statistics in the year2000[J]. Lancet Oncol.2001,2(9),533-543.
    [2] Parkin DM, Bray F:The burden of HPV-related cancers[J]. Vaccine.2006,24(Suppl.3)S11-S25.
    [3] AN Fiander. The prevention of cervical cancer in Africa[J]. Women's Health.2011,7(1),121-132.
    [4] Peto J, Gilham C, Fletcher O, et al. The cervical cancer epidemic that screening hasprevented in the UK[J]. Lancet.2004,364(9430),249-256.
    [5]于国瑞.实用肿瘤学第二册[M].北京:人民卫生出版社,1984:452.
    [6]连丽绢主编,林巧稚妇科肿瘤学.第三版[M].北京人民卫生出版社.2001:209-212.
    [7]拉莱·苏祖克,彭玉华,周康等.新疆不同民族子宫颈癌发病趋势分析[J].新疆医科大学学报.2006,29(7):569-571.
    [8]陈锐,李庭芳,王新玲等.新疆自治区宫颈浸润癌2417例临床流行病学回顾性分析[J].中华肿瘤防治杂志.2008,15:329-331.
    [9]章文华.子宫颈病变的诊治要点[M].北京:人民卫生出版社,2006:7-8.
    [10] SchiffmanM, CastlePE, JeronimoJ, etal. Human papillomavirus and cervicalcancer[J]. Lancet.2007,370:890-907.
    [11] Jung J. S., Preston G. M., Smith B. L. et al. Molecular structure of the water channelthrough aquaporin CHIP, the hourglass model[J]. J Biol Chem.1994,269:14648-14654.
    [12] Kong Y., Ma J., Dynamic mechanisms of the membrane water channelaquaporin-1(AQP1)[J]. Proc Natl Acad Sci.2001,98:14345-14349.
    [13] Morishita Y., Sakibe Y., Sasaki S. et al. Molecular mechanisms and drugdevelop-ment in aquaporin water channel diseases:aquaporin superfamily(superaquaporins): expansion of aquaporins restricted to multicellular organisms[J].J Pharmacol Sci.2004,96:276-279.
    [14] Cutler C. P., Philips C., Hazon N. Aquaporin8(AQP8)intestinal mRNA expressionincreases in response to salinity acclimation in yellow and silver Europeaneels(Anguilla anguilla)[J]. Comp. Biochem. Physiol.2009,153A, S78.
    [15] Tipsmark C. K., S rensen K. J., Madsen S. S. Aquaporin expression dynamics inosmoregulatory tissues of Atlantic salmon during smoltification and seawateracclimation[J]. J. Exp. Biol.2010,213,368-379.
    [16] Arge P, King LS, Yasui M, Guggino WB, et al. Aquaporin water channels-fromatomic structure to clinical medicine[J]. J Physiol.2002,542:3-16.
    [17] AgreP, KozonoD. Aquaporin water channels:molecular mechanisms forhumandisea-ses[J]. FEBS Lett.2003,555:72-78.
    [18] VerkmanAS. More than just water channels:unexpected cellular roles ofaquaporins[J]. J Cell Sci.2005,118:3225-3232.
    [19] Lehmann GL, Marinelli RA. Peritoneal sepsis downregulates liver expression ofAquaporin-8:a water channel involved in bile secretion[J]. Liver Int.2009,29(2):317-318.
    [20] Gao L, Gao Y, Li X et al. Aquaporins mediate the chemoresistance of humanmelanoma cells to arsenite[J]. Mol Oncol.2011,11.001. doi:10.1016/j. molonc.
    [21] Shi Z, Zhang T, Luo L, et al. Aquaporins in human breast cancer:Identification andinvolvement in carcinogenesis of breast cancer[J]. J Surg Oncol.2011,21. doi:10.1002/jso.22155.
    [22] Kao SC, Armstrong N, Condon B, et al. Aquaporin1is an independent prognosticfactor in pleural malignant mesothelioma[J]. Cancer.2011,21. doi:10.1002/cncr.26497.
    [23] Hao Xu,1Yong Xu,1Wenjie Zhang et al. Aquaporin-3positively regulates matrixmetalloproteinases via PI3K/AKT signal pathway in human gastric carcinomaSGC7901cells[J]. J Exp Clin Cancer Res.2011,30(1):86-91.
    [24] Zou LB, Zhang RJ, Tan YJ, et al. Identification of estrogen response element in theaquaporin-2gene that mediates estrogen-induced cell migration and invasion inhuman endometrial carcinoma[J]. J Clin Endocrinol Metab.2011,96(9):E1399-1408.
    [25] Warth A, Kroger S, Wolburg H. Redistribution of aquaporin-4in humanglioblastoma correlates with loss of agrin immunoreactivity from brain capillarybasal laminae[J]. Acta Neuropathol.2004,107:311-318.
    [26] Saadoun S, Papadopoulos MC, Davies DC, et al. Aquaporin-4expression isincreased in oedematous human brain tumors[J]. J Neurol Neurosurg Psychiatry.2002,72:262-265.
    [27] Yang JH, Shi YF, Cheng Q, Deng L. Expression and localization of aquaporin-5inthe epithelial ovarian tumors[J]. GynecolOncol.2006,100:294-299.
    [28] Arne Warth, Thomas Muley, Michael Meister, et al. Loss of aquaporin-4expressionand putative function in non-small cell lung cancer[J]. BMC Cancer.2011,11:161-169.
    [29] Xu H, Zhang Y, Wei W, et al. Differential expression of aquaporin-4in humangastric normal and cancer tissues[J]. Gastroenterol Clin Biol.2009,33(1Pt1):72-76.
    [30] McCoy ES, Haas BR, Sontheimer H. Water permeability through aquaporin-4isregulated by protein kinase C and becomes rate-limiting for glioma invasion[J].Neuroscience.2010,168(4):971-981.
    [31] Fischer H, Stenling R, Rubio C, et al. Differential expression of aquaporin8inhuman colonic epithelial cells and colorectal tumors[J]. BMC Physiol.2001,1:1.
    [32] Moon C, Soria JC, Jang SJ, et al. Involvement of aquaporins in colorectalcarcinogenesis[J]. Oncogene.2003,22:6699-6703.
    [33] Warth A, Simon P, Capper D, et al. Expression pattern of the water channelaquaporin-4in human gliomas is associated with blood-brain barrier disturbancebut not with patient survival[J]. J Neurosci Res.2007,85:1336-1346.
    [34]缪睿,李昌煜.水通道蛋白-依赖性细胞迁移的研究进展[J].中国药理学通报.2011,27(5):601-605.
    [35] Saadoun S, Papadopoulos MC, Hara-Chikuma M, Verkman AS, et al. Impairment ofangiogenesis and cell migration by targeted aquaporin-1gene disruption[J]. Nature.2005,434:786-792.
    [36] Hu J, Verkman AS. Increased migration and metastatic potential of tumor cellsexpressing aquaporin water channels[J]. FASEB J.2006,20:1892-1894.
    [37] Jiang, Y. Aquaporin-1activity of plasma membrane affects HT20colon cancer cellmigration. IUBMB Life.2009,61(10):1001-1009.
    [38] Bin K, Shi-Peng Z. Acetazolamide inhibits aquaporin-1expression and colon cancerxenograft tumor growth. Hepatogastroenterology.2011,58(110-111):1502-1506.
    [39]裴海平,刘卓,黄林生等.水通道蛋白1和3在结直肠癌组织中的表达及其意义[J].中华胃肠外科杂志.2011,14(4):275~278.
    [40]毕林涛,卢振霞,米东辉等.非小细胞肺癌细胞株H1975中水通道1的表达及意义[J].中国实验诊断学.2009,13(1):38~40.
    [41]刘锦源,张石江*,金宇1等.水通道蛋白1在肺腺癌组织中的表达和分布[J].南京医科大学学报.2008,28(4):445-448.
    [42] Hoque MO, Soria JC, Woo J, et al. Aquaporin1Is Overexpressed in Lung Cancerand Stimulates NIH-3T3Cell Proliferation and Anchorage-Independent Growth[J].Amer J Pathol.2006,168(4):1345-1353.
    [43] Machida Y, Ueda Y, Shimasaki M et al. Relationship of aquaporin1,3, and5expression in lung cancer cells to cellular differentiation, invasive growth, andmetastasis potential[J]. Hum Pathol.2011,42(5):669-678.
    [44] Morrissey JJ, London AN, Luo J, et al. Urinary biomarkers for the early diagnosis ofkidney cancer[J]. Mayo Clin Proc.2010,85(5):413-421.
    [45] Huang Y, Murakami T, Sano F, et al. Expression of aquaporin1in primary renaltumors:a prognostic indicator for clear-cell renal cell carcinoma[J]. Eur Urol.2009,56(4):690-698.
    [46] Otterbach F, Callies R, Kimmig R, et al. Aquaporin1expression in invasive breastcarcinomas. Pathologe[J].2008,29Suppl2:357-362.
    [47] Yin T, Yu S, Xiao L, et al. Correlation between the expression of aquaporin1andhypoxia-inducible factor1in breast cancer tissues[J]. J Huazhong Univ SciTechnolog Med Sci.2008,28(3):346-348.
    [48] Jung HJ, Park JY, Jeon HS, et al. Aquaporin-5:a marker protein for proliferation andmigration of human breastcancer cells[J]. PloS One.2011,6(12):e28492.
    [49] Xu H, Xu Y, Zhang W, et al. Aquaporin-3positively regulates matrixmetalloproteinases via PI3K/AKT signal pathway in human gastric carcinomaSGC7901cells[J]. J Exp Clin Cancer Res.2011,25(30):86.
    [50] Yang J, Yan C, Zheng W, et al. Proliferation inhibition of cisplatin and aquaporin5expression in human ovariancancer cell CAOV3[J]. Arch Gynecol Obstet.2011,26.[Epub ahead of print].
    [51] Soria LR, Gradilone SA, Larocca MC, et al. Glucagon induces the gene expressionof aquaporin-8but not that of aquaporin-9water channels in the rat hepatocyte[J].Am J Physiol Regul Integr Comp Physiol.2009,296(4):R1274-1281.
    [52] Larocca MC, Soria LR, Espelt MV, et al. Knockdown of hepatocyte aquaporin-8byRNA interference induces defective bile canalicular water transport[J]. Am JPhysiol Gastrointest Liver Physiol.2009,296(1):G93-100.
    [53] Lebeck J, Gena P, O'Neill H, et al. Estrogen prevents increased hepatic aquaporin-9expression and glycerol uptake during starvation[J]. Am J Physiol GastrointestLiver Physiol.2011,23.[Epub ahead of print].
    [54]文建国,张宁,王庆伟等.子宫内膜腺癌组织中水通道蛋白12的表达[J].郑州大学学报(医学版).2009,44(2):301-303.
    [55]杨丰.水通道蛋白1在子宫内膜癌组织中的表达及意义[J].实验预防医学.2011,18(1):104-105.
    [56]贾丽棉,许晓峰,张洛英.水通道蛋白2在子宫内膜癌中表达及与组织学分级之间的关系[J].中国当代医药.2010,17(31):40-41.
    [57]李留霞,赵艳萍,文建国等.卵巢上皮性癌组织中水通道蛋白3的表达[J].郑州大学学报(医学版).2008,43(2):329-332.
    [58]杨建华,郑伟,石一复等.顺铂对卵巢癌SKOV3细胞水通道蛋白5表达的影响及调控[J].细胞生物学杂志.2008,30:771-775.
    [59]王莉,张建华,张华等. AQP8在正常人绒毛滋养层细胞与绒癌JAR细胞株中的表达[J].重庆医科大学学报.2010(35);4:512-515.
    [60]丁凤云,马桂芳,宋署等.宫颈癌组织中水通道蛋白1mRNA的表达及临床意义研究[J]. Chinese General Practice.2011,14(5B):1532-1534.
    [61]张红彬,孔红霞,都志伟.宫颈鳞状细胞癌发生过程中水通道蛋白1缺氧诱导因子一1α和血管内皮生长因子的表达变化[J].中国实用医刊.2008,35(9):5-7.
    [62]苟彩霞,阿布力孜·阿布杜拉,刘开江.维吾尔族妇女宫颈病变的AQP4蛋白表达及其临床意义[J].新疆医科大学学报.2011,34(5):482-485.
    [63]姚济芬,周彩云,韦兰芳等.子宫颈癌组织中水通道蛋白8和bcl-2蛋白的表达及其相关性[J].中华妇产科杂志.2008(43);3:205-208.
    [64] Beaudette PC, Chlup M, Yee J, et al. Relationships of root conductivity andaquaporin gene expression in Pisum sativum:diurnal patterns and the response toHgCl2and ABA[J]. J Exp Bot.2007,58(6):1291-300.
    [65] Walid Sadok and Thomas R. Sinclair. Transpiration response of ‘slow-wilting’ andcommercial soybean(Glycine max(L.)Merr.)genotypes to three aquaporininhibitors[J]. J Exp Bot.2010,61(3):821-829.
    [66] Sack L, Streeter CM, Holbrook NM. Hydraulic analysis of water flow throughleaves of sugar maple and red oak[J]. Plant Physiology.2004,134:1824-1833.
    [67] Ye Q, Holbrook NM, Zwieniecki MA. Cell-to-cell pathway dominatesxylem-epidermis hydraulic connection in Tradescantia fluminensis(Vell.Conc.)leaves[J]. Planta.2008,227:1311-1317.
    [68] Nardini A, Salleo S, Andri S. Circadian regulation of leaf hydraulic conductance insunflower(Helianthus annuus L. cv. Margot)Plant[J]. Cell and Environment.2005,28:750-759.
    [69] Cochard H, Venisse J-S, Barigah TS, Brunel N, Herbette S, Guilliot A, Tyree MT,Sakr S. Putative role of aquaporins in variable hydraulic conductance of leaves inresponse to light[J]. Plant Physiology.2007,143:122-133.
    [70] Xiang Y, Ma B, Li T, et al. Acetazolamide inhibits aquaporin-1protein expressionand angiogenesis[J]. Acta Pharmacol Sin.2004,25(6):812-816.
    [71] Guan G, Dong Z. Effect of inhibiting aquaporin-1on proliferation and apoptosis ofthe Hep-2cell[J]. Lin Chuang Er Bi Yan Hou Ke Za Zhi.2006,20(21):988-991.
    [72] Bin K, Shi-Peng Z. Acetazolamide inhibits aquaporin-1expression and colon cancerxenograft tumor growth[J]. Hepatogastroenterology.2011,(110-111):1502-1506.
    [73] Monzani E, Shtil AA, La Porta CA. The water channels, new druggable targets tocombat cancer cell survival, invasiveness and metastasis[J]. Curr Drug Targets.2007,8(10):1132-1137.
    [74] Ma B, Xiang Y, Li T, et al. Inhibitory effect of topiramate on Lewis lung carcinomametastasis and its relation with AQP1water channel[J]. Acta Pharmacol Sin.2004,25(1):54-60.
    [75] Tran ND, Kim S, Vincent HK, et al. Aquaporin-1-mediated cerebral edemafollowing traumatic brain injury:effects of acidosis and corticosteroidadministration[J]. J Neurosurg.2010,112(5):1095-1104.
    [76] Kitahara T, Fukushima M, Uno Y, et al. Up-regulation of cochlear aquaporin-3mRNA expression after intra-endolymphatic sac application of dexamethasone[J].Neurol Res.2003,25(8):865-870.
    [77] Naldini, L. et al. In vivo gene delivery and stable transduction of nondividing cellsby a lentiviral vector[J].1996, Science.272,263-267.
    [78] Zufferey, R., Nagy, D., Mandel, R. J., Naldini, L., and Trono, D. Multiply attenuatedlentiviral vector achieves efficient gene delivery in vivo[J]. Nat Biotechnol.1997,15,871-875.
    [79] Escarpe, P. et al. Development of a sensitive assay for detection of replication-competent recombinant lentivirus in largescale HIV-based vector preparations[J].Mol Ther.2003,8,332-341.
    [80] Xiang-yong Li,1,2Yiu-kay Lai,3Jin-fang Zhang, et al. Lentivirus-Mediated RNAInterference Targeting Bax Inhibitor-1Suppresses Ex Vivo Cell Proliferation and InVivo Tumor Growth of Nasopharyngeal Carcin[J]. Hum Gene Ther.2011,22(10):1201-1208.
    [81] Kim, D. H., Behlke, M. A., Rose, S. D., et al. Synthetic dsRNA Dicer substratesenhance RNAi potency and efficacy[J]. Nat. Biotechnol.2005,23,222-226.
    [82] Siolas, D., Lerner, C., Burchard, J., et al. Synthetic shRNAs as potent RNAitriggers[J]. Nat. Biotechnol.2005,23,227-231.
    [83] Lei Jiang, Fule Wang a, Feiyan Lin, et al. Lentivirus-mediated overexpression ofTGF- inducible early gene1inhibits SW1990pancreatic cancer cell growth[J].Cell Biol Intern.2011,35,891-896.
    [84] DiGiusto DL, Krishnan A, Li L, Li H, Li S, Rao A, et al. RNA-based gene therapyfor HIV with lentiviral vector-modified CD34(+)cells in patients undergoingtransplantation for AIDS-related lymphoma[J]. Sci Transl Med.2010,2:36-43.
    [85] Sumimoto H, Kawakami Y. The RNA silencing technology applied by lentiviralvectors in oncology[J]. Methods Mol Biol.2010,614:187-199.
    [86]李艳菊,郑智华,刘景丰等. APE1基因RNAi慢病毒载体的构建与鉴定[J].福建医科大学学报.2010,44(2):86-90.
    [87] Pham PV, Phan NL, Nguyen NT, et al. Differentiation of breast cancer stem cells byknockdown of CD44:promising differentiation therapy[J]. J Transl Med.2011,9(1):209.
    [88]关婧,孙爱民,王莉慧等.慢病毒介导RNAi抑制大肠癌细胞APRIL表达对化疗敏感性的影响[J].南方医科大学学报.2011,31(9):1600-1604.
    [89] Cui X, Xu D, Lv C, et al. Suppression of MED19expression by shRNA inducesinhibition of cell proliferation and tumorigenesis in human prostate cancer cells[J].BMB Rep.2011,44(8):547-52.
    [90] Wang XT, Xie YB, Xiao QLentivirus-mediated RNA interference targeting E2F-1inhibits human gastric cancer MGC-803cell growth in vivo[J]. Exp Mol Med.2011,43(11):638-645.
    [91] Zhang LP, Shi XY, Zhao CY, et al. RNA interference of pax2inhibits growth oftransplanted human endometrialcancer cells in nude mice[J]. Chin J Cancer.2011,30(6):400-406.
    [92] Barrès V, Ouellet V, Lafontaine J, et al. An essential role for Ran GTPase inepithelial ovarian cancer cell survival[J]. Mol Cancer.2010,13(9):272.
    [93] Wu Z, Li G, Wu L, et al. Cripto-1overexpression is involved in the tumorigenesis ofnasopharyngeal carcinoma[J]. BMC Cancer.2009,6(9):315.
    [94] Yang G, Huang C, Cao J, et al. Lentivirus-mediated shRNA interference targetingSTAT3inhibits human pancreatic cancer cell invasion[J]. World J Gastroenterol.2009,15(30):3757-3766.
    [95] Tan Y, Cheung M, Pei J, et al. Upregulation of DLX5promotes ovarian cancer cellproliferation by enhancing IRS-2-AKT signaling[J]. Cancer Res.2010,70(22):9197-9206.
    [96] Pearce L, Morgan L, Lin TT, et al. Genetic modification of primary chroniclymphocytic leukemia cells with alentivirus expressing CD38[J]. Haematologica.2010,95(3):514-517.
    [97]孔恒,黄宗海,陈海金等.慢病毒介导的双自杀基因对胃癌细胞的杀伤作用[J].南方医科大学学报.2010,30(1):47-50.
    [98] Goold HD, Escors D, Conlan TJ, et al. Conventional dendritic cells are required forthe activation of helper-dependent CD8T cell responses to a model antigen aftercutaneous vaccination with lentiviral vectors[J]. J Immunol.2011,186(8):4565-4572.
    [99] DuPage M, Cheung AF, Mazumdar C, et al. Endogenous T cell responses to antigensexpressed in lung adenocarcinomas delay malignant tumor progression[J]. CancerCell.2011,19(1):72-85.
    [100]Adotévi O, Mollier K, Neuveut C, et al. Targeting human telomerase reversetranscriptase with recombinant lentivector is highly effective to stimulate antitumorCD8T-cell immunity in vivo[J]. Blood.2010,115(15):3025-3032.
    [101]Colombetti S, Lévy F, Chapatte L. IL-7adjuvant treatment enhances long-termtumor-antigen-specific CD8+T-cell responses after immunization with recombinantlentivector[J]. Blood.2009,113(26):6629-6637.